The Mediterranean diet reduces the genetic risk of chromosome 9p21 for myocardial infarction in an Asian population community cohort.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
05 12 2019
Historique:
received: 06 08 2019
accepted: 18 11 2019
entrez: 6 12 2019
pubmed: 6 12 2019
medline: 11 11 2020
Statut: epublish

Résumé

The interaction of genetic susceptibility and dietary habits in cardiovascular disease (CVD) remains undetermined. The purpose of this study was to investigate whether a Mediterranean dietary style modified the genetic risk of developing CVD in a Chinese cohort. A total of 2098 subjects with dietary information from a Chinese community cohort (CVDFACTS) were enrolled. Candidate genes, including SNP markers rs1333049 (CDKN2B, 9p21.3), rs17465637 (MIA3, 1q41) and rs501120 (CXCL12, 10q11.21), were genotyped to analyze the association with future CVD. The impact of dietary pattern was also analyzed according to adherence to the diet using the Mediterranean Diet Score (MDS). After an average follow-up of 7.8 years, only the C risk allele of rs1333049 at chromosome 9p21.3 was associated with a higher risk of MI with either an additive [HR = 1.78, 95% CI:1.23-2.5] or a recessive model [HR = 2.40, 95% CI: 1.42-4.04], and the CC genotype had a higher risk of developing MI (p = 0.009, log-rank test). There was no significant difference in the association of the lipid profile with future CV outcomes among the MDS tertiles. However, the high MI risk of the CC genotype in individuals consuming a less healthy diet (MDS1) (HR: 6.39, 95% CI: 1.74-23.43) significantly decreased to 2.38 (95% CI: 0.57-10.04) in individuals consuming a healthier diet (MDS3), indicating that a healthier dietary pattern (higher MDS) modified the risk of developing MI in carriers of variants in CDKN2B. In conclusion, genetic variants of CDKN2B at 9p21 were significantly associated with future MI risk in a Chinese cohort, and the genetic risk of MI could be modified by a healthier diet.

Identifiants

pubmed: 31804579
doi: 10.1038/s41598-019-54938-w
pii: 10.1038/s41598-019-54938-w
pmc: PMC6895036
doi:

Substances chimiques

ARNT protein, human 0
CDKN2B protein, human 0
CXCL12 protein, human 0
Chemokine CXCL12 0
Cyclin-Dependent Kinase Inhibitor p15 0
Aryl Hydrocarbon Receptor Nuclear Translocator 138391-32-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

18405

Références

Circ J. 2008 Aug;72(8):1213-7
pubmed: 18654002
Circ Cardiovasc Genet. 2011 Dec;4(6):661-72
pubmed: 22042884
Am J Clin Nutr. 2016 Apr;103(4):1179-84
pubmed: 26961926
BMJ Open. 2014;4(8):e005438
pubmed: 25232560
N Engl J Med. 2016 Dec 15;375(24):2349-2358
pubmed: 27959714
Stroke. 2008 Dec;39(12):3152-8
pubmed: 18988909
N Engl J Med. 2007 Aug 2;357(5):443-53
pubmed: 17634449
Adv Nutr. 2014 Jan 01;5(1):7-15
pubmed: 24425715
Eur Heart J. 2016 Jul 01;37(25):1993-2001
pubmed: 27109584
Circ Cardiovasc Genet. 2009 Aug;2(4):338-46
pubmed: 20031605
Atherosclerosis. 2011 Jan;214(1):101-6
pubmed: 21044781
Stroke. 2006 Apr;37(4):1060-4
pubmed: 16514099
Ann Hum Genet. 2011 Jul;75(4):475-82
pubmed: 21463265
BMJ. 1995 Dec 2;311(7018):1457-60
pubmed: 8520331
Stroke. 2016 Sep;47(9):2262-8
pubmed: 27491737
Circulation. 2018 Sep 11;138(11):e160-e168
pubmed: 30354383
N Engl J Med. 2003 Jun 26;348(26):2599-608
pubmed: 12826634
Eur Heart J. 2010 May;31(9):1132-41
pubmed: 20231156
Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1467-73
pubmed: 20395598
BMC Med Genet. 2014 Dec 21;15:140
pubmed: 25528061
Circ J. 2012;76(4):950-6
pubmed: 22322877
Diabetes Care. 2013 Nov;36(11):3803-11
pubmed: 23942586
Atherosclerosis. 2009 Nov;207(1):26-8
pubmed: 19467655
Nat Genet. 2011 Mar 06;43(4):333-8
pubmed: 21378990
Atherosclerosis. 2013 Nov;231(1):136-40
pubmed: 24125424
Bioessays. 2014 May;36(5):526-37
pubmed: 24706458
BMC Cardiovasc Disord. 2017 Jan 28;17(1):42
pubmed: 28129736
Medicine (Baltimore). 2015 Sep;94(39):e1538
pubmed: 26426617
Int J Epidemiol. 2019 Dec 1;48(6):1824-1838
pubmed: 31056682
J Hum Genet. 2008;53(4):357-359
pubmed: 18264662
Stroke. 2009 May;40(5):1578-84
pubmed: 19286580

Auteurs

Hsin-Bang Leu (HB)

Institute of Clinical Medicine and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan. hsinbangleu@gmail.com.
Healthcare and Service Center, Taipei Veterans General Hospital, Taipei, Taiwan. hsinbangleu@gmail.com.
Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. hsinbangleu@gmail.com.

Chia-Min Chung (CM)

Environment-Omics-Diseases Research Centre, China Medical University Hospital, Taichung, Taiwan.
Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.

Jaw-Wen Chen (JW)

Institute of Clinical Medicine and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan.
Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Institute of Pharmacology, National Yang-Ming University, Taipei, Taiwan.
Department of Medical Research, Taipei Veterans General Hospital, Taipei, Taiwan.

Wen-Harn Pan (WH)

Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. pan@ibms.sinica.edu.tw.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH